Morgan Stanley Maintains Equal-Weight on United Therapeutics, Raises Price Target to $566

Benzinga · 5d ago
Morgan Stanley analyst Terence Flynn maintains United Therapeutics (NASDAQ:UTHR) with a Equal-Weight and raises the price target from $515 to $566.